Prof. Biao Xu, Nanjing University, China
Prof. Biao Xu, born in March 1981 in Huainan, Anhui, is a distinguished academic at the School of Government, Nanjing University. He holds a Ph.D. in Business Administration and has a profound background in public administration and marketing. Specializing in health policies, health economy, and government economic management, Prof. Xu is currently the director of the Center for Health Management and Care Security Policy Research. His notable projects include AI-based doctor-patient communication systems and public trust crisis management. He has published extensively in leading journals on topics such as public trust and health management. 📚✍️
Publication profile
Scopus
🎓 Education and Academic Background
Xu Biao, born in Huainan, Anhui, China in March 1981, is a distinguished scholar and professor at Nanjing University. He holds a Ph.D. in Business Administration from Nanjing University, completed in 2009, a Master’s degree in Business Administration (Marketing) from the same university (2006), and a B.Sc. in Public Administration from Anhui University (2003). Following his Ph.D., he was a postdoctoral fellow at the Center for Health Management and Care Security Policy Research at Nanjing University (2009-2011). 📚
🧑🏫 Professional Experience
Xu has a robust academic career, serving as a Professor at Nanjing University’s School of Government since 2019, with previous roles including Associate Professor (2013-2018) and Lecturer (2011-2012). He has also been a Research Associate at the Center for Health Management and Care Security Policy Research since 2011. 🏫
Research Focus
Dr. Xu Biao, a renowned scholar at Nanjing University, focuses on diverse research areas within health and economic policies. His primary interests lie in health policy management, examining cost-effectiveness in diabetes treatments🩺, and public behavior in healthcare decisions💉. Dr. Xu also explores innovation adoption in healthcare🏥, particularly addressing resistance among professionals to new practices. Additionally, he delves into public trust dynamics during crises🤝 and the impact of government policies on enterprise innovation and sustainable development🌍. His work often intersects health economics and public administration, reflecting a commitment to enhancing healthcare systems and public trust.
Publication Top Notes
- The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China 🩺 (2024) – 0 Citations
- Double-edged sword of knowledge inertia: Overcoming healthcare professionals’ resistance in innovation adoption 📚 (2024) – 0 Citations
- Heuristics in vaccination Decision-Making for newly developed Vaccines: Understanding the public’s imitative behavior 💉 (2024) – 0 Citations
- Conflicts, trust toward the acquirer from emerging economies and post-acquisition cooperation intention 🤝 (2023) – 0 Citations
- Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus 🦠 (2021) – 30 Citations
- How does renqing influence purchase intentions in the Chinese business-to-business context? 🛒 (2021) – 7 Citations
- R&D internationalization and green innovation? Evidence from Chinese resource enterprises and environmental enterprises 🌍 (2019) – 20 Citations
- Do government R&D subsidies cultivate enterprises’ voluntary national/industry standard-setting for sustainable development? 🏛️ (2019) – 3 Citations
- Presence of hepatitis B virus markers in umbilical cord blood: Exposure to or infection with the virus? 👶🦠 (2019) – 34 Citations
- Know to grow: the role of knowledge integration in marketing dynamic capabilities 📈 (2019) – 3 Citations